LCAR Projected Dividend Yield
Lescarden Inc ( OTCBB : LCAR )Lescarden is engaged in the research, testing and development of medications for the control and cure of various diseases and the licensing of its technologies for commercialization by other companies. Co. is focused on wound healing, clinical skin care, osteoarthritis and cancer applications. Co.'s primary product line is Catrix Wound Dressing, a powder derived from bovine cartilage in the management of chronic lesions and burns, and to be applied to non-healing wounds such as decubitus ulcers, venous stasis ulcers, and diabetic ulcers. Co. also has a line of Catrix-based skin care products targeting the plastic surgery, dermatology and medical spa markets. 20 YEAR PERFORMANCE RESULTS |
LCAR Dividend History Detail LCAR Dividend News LCAR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |